期刊
EXPERIMENTAL CELL RESEARCH
卷 312, 期 12, 页码 2231-2237出版社
ELSEVIER INC
DOI: 10.1016/j.yexcr.2006.03.024
关键词
p43; endothelial-monocyte activating; polypeptide II; proteinase; anti-angiogenesis
资金
- NHLBI NIH HHS [HL-75764, HL-60061, HL-03981] Funding Source: Medline
The cleaved approximate to 22-kDa form of Endothelial-Monocyte Activating Polypeptide [mature (in) EMAP II] functions as a potent inhibitor of tumor growth. Although the anti-tumor effect of mEMAP II has been described, little is known regarding the cleavage of mEMAP II from its precursor form (pEMAP II). We determined that pEMAP II is expressed at the cell membrane surface and proteinases MMP-9, elastase, and cathepsin L release protein fragments consistent with mEMAP II molecular mass. MMP-9 and elastase generate a approximate to 25-26 kDa spanning fragments, while cathepsin L generates a approximate to 22 kDa fragment. Although several fragments are processed from pEMAP II within a 44 AA residue stretch, cathepsin L cleaves pEMAP II within 4 amino acids of the determined N-terminal sequence, suggesting that this region is sensitive to proteinases. (c) 2006 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据